Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Locally Advanced Breast Cancer 1Hepatitis 1Fibrosis 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Pentoxifylline 2Blood Specimen Collection 2contrast agent BR1 1alpha-Tocopherol 1Tocopherols 1Spermine Synthase 1Sonazoid 1Propofol 1Probiotics 1N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide 1Mass Screening 1Iodides 1Hyperbaric Oxygenation 1Hematologic Tests 1Gemcitabine 1Diet, Mediterranean 1Dexmedetomidine 1Clinical Protocols 1BCG Vaccine 1Arthroplasty, Replacement, Knee 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Fibrosis × Clinical Protocols × Clear all
NCT05429190 2023-11-29

Validation of SMS Protocol for HCC Screening in High-risk Patients

Erasmus Medical Center

Unknown
470 enrolled
Gastrointestinal

Fibrosis, Hepatitis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡